{"id":753996,"date":"2023-05-02T18:44:27","date_gmt":"2023-05-02T22:44:27","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/uniqure-announces-major-presence-at-upcoming-american-society-of-gene-and-cell-therapy-asgct-annual-meeting\/"},"modified":"2023-05-02T18:44:27","modified_gmt":"2023-05-02T22:44:27","slug":"uniqure-announces-major-presence-at-upcoming-american-society-of-gene-and-cell-therapy-asgct-annual-meeting","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/uniqure-announces-major-presence-at-upcoming-american-society-of-gene-and-cell-therapy-asgct-annual-meeting\/","title":{"rendered":"uniQure Announces Major Presence at Upcoming\u00a0American Society of Gene and Cell Therapy (ASGCT) Annual Meeting"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">LEXINGTON, Mass. and AMSTERDAM, May  02, 2023  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=d4elynp2l9NiXuDj2kfwdM2PES-u25VTXtw4tZj0gd9D3yC86FUfj5e10Nu5VdJ6leHZcf98VwxwgekOO4kSwQ==\" rel=\"nofollow noopener\" target=\"_blank\">uniQure N.V.<\/a> (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced that 12 data presentations, including two oral presentations, will be delivered at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting being held May 16-20 in Los Angeles, California.<\/p>\n<p align=\"justify\">\u201cOur presentations at ASGCT highlight the innovative work of our uniQure research scientists in expanding our pipeline capabilities, as well as that of our CMC and Operations team with their industry-leading expertise in AAV gene therapy manufacturing,\u201d stated <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=AGc41TFWHblmd2tk-O_l26QesC3rtXSnytBjHWorOv-Qb9DYRX0CviXe997HAJZC0jZY0CaEtsnA-_4yYULJIxgTWAxrMg0eDsuiAtr_Rk8GnizSRX5dvSg0dd_sBGdIeR0UBV3aGtMTULsg7yFcoTh2HJU75h4_bwmKegTEI84=\" rel=\"nofollow noopener\" target=\"_blank\">Ricardo Dolmetsch, Ph.D.<\/a>, president of research and development at uniQure. \u201cWe are particularly excited to share our progress in developing a gene therapy approach to treating a form of ALS caused by mutant C9orf72.\u201d<\/p>\n<p align=\"justify\">Specific details on uniQure\u2019s presentations taking place at ASGCT include:<\/p>\n<ul>\n<li style=\"text-align:justify\">\n          <strong>Title: <\/strong><br \/>\n          <em>AAV vector DNA carrying two concatenated miRNA stem-loops is highly homogenous and stable in GLP-grade AAV product <\/em>(Abstract #110)<br \/><strong>Presenter: <\/strong> Chenxia He, Director, Gene Therapy Technology Innovation, uniQure<br \/><strong>Oral Session Title: <\/strong>AAV Vectors &#8211; Product Development Manufacturing: Analytics &amp; Stability Studies<br \/><strong>Date and Time: <\/strong>Thursday, May 18, 1:45 \u2013 2:00 p.m. PDT<\/li>\n<\/ul>\n<ul>\n<li style=\"text-align:justify\">\n          <strong>Title: <\/strong><br \/>\n          <em>Lowering of toxic dipeptide proteins and phenotype rescue in an ALS mouse model treated with AAV-miQURE<\/em><br \/>\n          <sup><br \/>\n            <em>\u00ae<\/em><br \/>\n          <\/sup><br \/>\n          <em> targeting the repeat expansion-containing C9orf72 transcripts <\/em>(Abstract #165)<br \/><strong>Presenter: <\/strong>Vanessa Zancanella, Sr. Scientist Global Research, uniQure<br \/><strong>Oral Session Title: <\/strong>Neurological Gene Therapies in Advanced Stages of Clinical Translation<br \/><strong>Date and Time: <\/strong>Thursday, May 18, 3:45 \u2013 4:00 p.m. PDT<\/li>\n<\/ul>\n<ul>\n<li style=\"text-align:justify\">\n          <strong>Title: <\/strong><br \/>\n          <em>The capsid race: multiplexed analysis and comparison of rationally engineered AAV CNS capsids in vivo <\/em>(Abstract #448)<br \/><strong>Presenter:<\/strong> Leonard Khirug, Senior Director, Technology Innovation, uniQure<br \/><strong>Poster Session Date and Time: <\/strong>Wednesday, May 17, 12:00 p.m. PDT<\/li>\n<\/ul>\n<ul>\n<li style=\"text-align:justify\">\n          <strong>Title: <\/strong><br \/>\n          <em>Phase-appropriate viral clearance studies for AAV manufacturing process <\/em>(Abstract #415)<br \/><strong>Presenter:<\/strong> Aidan Hawkins, Engineer III DSP, Drug Substance Development, uniQure<br \/><strong>Poster Session Date and Time: <\/strong>Wednesday, May 17, 12:00 p.m. PDT<\/li>\n<\/ul>\n<ul>\n<li style=\"text-align:justify\">\n          <strong>Title: <\/strong><br \/>\n          <em>Next-generation Rep-Cap Dual baculoviruses for AAV production in insect cells <\/em>(Abstract #422)<br \/><strong>Presenter:<\/strong> Finny Varghese, Sr. Scientist Virology, Baculovirus Production Unit, Biological Starting Materials, uniQure<br \/><strong>Poster Session Date and Time: <\/strong>Wednesday, May 17, 12:00 p.m. PDT<\/li>\n<\/ul>\n<ul>\n<li style=\"text-align:justify\">\n          <strong>Title: <\/strong><br \/>\n          <em>Development of a gene therapy for Alzheimer Disease by lowering toxic APOE while simultaneously overexpressing a protective APOE variant <\/em>(Abstract #373)<br \/><strong>Presenter:<\/strong> Amila Zuko, Scientist, Global Research, uniQure<br \/><strong>Poster Session Date and Time: <\/strong>Wednesday, May 17, 12:00 p.m. PDT<\/li>\n<\/ul>\n<ul>\n<li style=\"text-align:justify\">\n          <strong>Title:\u00a0<\/strong><br \/>\n          <em>Preclinical proof-of-concept of AMT-260, a novel AAV9-dual microRNA-based vector targeting GRIK2 for the treatment of temporal lobe epilepsy<\/em> (Abstract #1159)<br \/><strong>Presenter:<\/strong> Nick Pearson, Sr. Director Toxicology &amp; Translational Safety, Non-Clinical, uniQure\u00a0<br \/><strong>Poster Session Date and Time: <\/strong>Thursday, May 18, 12:00 p.m. PDT<\/li>\n<\/ul>\n<ul>\n<li style=\"text-align:justify\">\n          <strong>Title: <\/strong><br \/>\n          <em>Novel method of producing AAV capsid libraries in insect cells <\/em>(Abstract #1230)<br \/><strong>Presenter:<\/strong> Leonard Khirug, Senior Director, Technology Innovation, uniQure<br \/><strong>Poster Session Date and Time: <\/strong>Thursday, May 18, 12:00 p.m. PDT<\/li>\n<\/ul>\n<ul>\n<li style=\"text-align:justify\">\n          <strong>Title: <\/strong><br \/>\n          <em>Insect cell baculovirus expression platform for large scale production of rAAV <\/em>(Abstract #1014)<br \/><strong>Presenter:<\/strong> Sandra Bennun, Associate Director\/Team Lead USP, Drug Substance Development, uniQure<br \/><strong>Poster Session Date and Time: <\/strong>Thursday, May 18, 12:00 p.m. PDT<\/li>\n<\/ul>\n<ul>\n<li style=\"text-align:justify\">\n          <strong>Title: <\/strong><br \/>\n          <em>Heat Stress on Baculovirus Infected SF+ Cells May Lead to Product Loss During Harvest <\/em>(Abstract #910)<br \/><strong>Presenter:<\/strong> Robin Mailhot, Sr. Engineer II USP, Drug Substance Development, uniQure<br \/><strong>Poster Session Date and Time: <\/strong>Thursday, May 18, 12:00 p.m. PDT<\/li>\n<\/ul>\n<ul>\n<li style=\"text-align:justify\">\n          <strong>Title: <\/strong><br \/>\n          <em>Development of AbQURE\u2122, an a-synuclein targeting vectorized antibody strategy: First in vivo proof of mechanism in wild type mice <\/em>(Abstract #1026)<br \/><strong>Presenter:<\/strong> \u015eeyda A\u00e7ar Broekmans, Sr. Scientist, Global Research, uniQure<br \/><strong>Poster Session Date and Time: <\/strong>Thursday, May 18, 12:00 p.m. PDT<\/li>\n<\/ul>\n<ul>\n<li style=\"text-align:justify\">\n          <strong>Title: <\/strong><br \/>\n          <em>Combining vectorized antibody and miRNA lowering strategies for synucleinopathies <\/em>(Abstract #1503)<br \/><strong>Presenter:<\/strong> \u015eeyda A\u00e7ar Broekmans, Sr. Scientist, Global Research, uniQure<br \/><strong>Poster Session Date and Time: <\/strong>Friday, May 19, 12:00 p.m. PDT<\/li>\n<\/ul>\n<p align=\"justify\">\n        <strong>About uniQure<br \/><\/strong>uniQure is delivering on the promise of gene therapy \u2013 single treatments with potentially curative results. The recent approvals of our gene therapy for hemophilia B \u2013 an historic achievement based on more than a decade of research and clinical development \u2013 represent a major milestone in the field of genomic medicine and ushers in a new treatment approach for patients living with hemophilia. We are now leveraging our modular and validated technology platform to advance a\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Jws2D2siRdTAPO6LcD0jeuPOBQUl2s8zGLd08tDRZnmZt_E0KpdHE8JFw6nCvZbRTaE2v1lblYzwn9tG1r16w4Wc5OSv7fYo98kLj23rqi9jYsprVeAYhlLWY2YWr5zW5-sCJKeztQg54aczrJhEWUEpfjdn4x82vOJ4t17DIrPNug-9YoeiISfP7MM68pbSEBN5PvR8WjMmAmqQ6jSVbN9NvI0tEWjn7IDA_aS3iWD9N7cZinf9a6vsP5XJAjhz\" rel=\"nofollow noopener\" target=\"_blank\">pipeline<\/a>\u00a0of proprietary gene therapies for the treatment of patients with\u00a0Huntington&#8217;s\u00a0disease, refractory temporal lobe epilepsy, ALS, Fabry disease, and other severe diseases.\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=-LI01ng2_heZf2qT3UJ4QX8AzTwIk-upal_Wm9jAcBoo0wTIeZPedVYZ9V5jpJzcf49gwHEzfe1EE88tG35N_lZhbMtNd6deuFszGaGxPEYv_fs7Ol-BUeu6de45lVmzj-7fJI2qk1xJuqqzTTcuReB2xoYfJhH4Ul629qnafb2jD4opTWpy13CFn8xbydpUsHCYA8OsxvVaO_enzN5hgr9hw6iU7POn_WKIbMnen24=\" rel=\"nofollow noopener\" target=\"_blank\">www.uniQure.com<\/a><\/p>\n<table style=\"border-collapse: collapse;width:100%;border-collapse:collapse\">\n<tr>\n<td style=\"max-width:33%;width:33%;min-width:33%;vertical-align: bottom\">\n            <strong>uniQure Contacts:<br \/><\/strong><br \/>\n            <br \/>\n            <strong>FOR INVESTORS:<br \/><\/strong><br \/>\n            <br \/>\n            <strong>Maria E. Cantor<\/strong><br \/>\n            <br \/>Direct: 339-970-7536<br \/>Mobile: 617-680-9452<br \/><a href=\"mailto:m.cantor@uniQure.com\" rel=\"nofollow noopener\" target=\"_blank\">m.cantor@uniQure.com<\/a><\/td>\n<td style=\"max-width:33%;width:33%;min-width:33%;vertical-align: bottom\">\n            <strong>Chiara Russo<\/strong><br \/>\n            <br \/>Direct: 617-306-9137<br \/>Mobile: 617-306-9137<br \/><a href=\"mailto:c.russo@uniQure.com\" rel=\"nofollow noopener\" target=\"_blank\">c.russo@uniQure.com<\/a><\/td>\n<td style=\"max-width:34%;width:34%;min-width:34%;vertical-align: bottom\">\n            <strong><br \/>\n              <br \/>FOR MEDIA:<br \/><\/strong><br \/>\n            <br \/>\n            <strong>Tom Malone<\/strong><br \/>\n            <br \/>Direct: 339-970-7558<br \/>Mobile: 339-223-8541<br \/><a href=\"mailto:t.malone@uniQure.com\" rel=\"nofollow noopener\" target=\"_blank\">t.malone@uniQure.com<\/a><\/td>\n<\/tr>\n<\/table>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzMDQzMCM1NTcwNjk4IzIwODA0MDY=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/NWJlOGU4YWEtYjA2Zi00YWIyLWI5ZWYtNDg0ZTE3MzY3MjMxLTEwOTE5Nzc=\/tiny\/uniQure-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>LEXINGTON, Mass. and AMSTERDAM, May 02, 2023 (GLOBE NEWSWIRE) &#8212; uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced that 12 data presentations, including two oral presentations, will be delivered at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting being held May 16-20 in Los Angeles, California. \u201cOur presentations at ASGCT highlight the innovative work of our uniQure research scientists in expanding our pipeline capabilities, as well as that of our CMC and Operations team with their industry-leading expertise in AAV gene therapy manufacturing,\u201d stated Ricardo Dolmetsch, Ph.D., president of research and development at uniQure. \u201cWe are particularly excited to share our progress in developing a &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/uniqure-announces-major-presence-at-upcoming-american-society-of-gene-and-cell-therapy-asgct-annual-meeting\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;uniQure Announces Major Presence at Upcoming\u00a0American Society of Gene and Cell Therapy (ASGCT) Annual Meeting&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-753996","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>uniQure Announces Major Presence at Upcoming\u00a0American Society of Gene and Cell Therapy (ASGCT) Annual Meeting - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/uniqure-announces-major-presence-at-upcoming-american-society-of-gene-and-cell-therapy-asgct-annual-meeting\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"uniQure Announces Major Presence at Upcoming\u00a0American Society of Gene and Cell Therapy (ASGCT) Annual Meeting - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"LEXINGTON, Mass. and AMSTERDAM, May 02, 2023 (GLOBE NEWSWIRE) &#8212; uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced that 12 data presentations, including two oral presentations, will be delivered at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting being held May 16-20 in Los Angeles, California. \u201cOur presentations at ASGCT highlight the innovative work of our uniQure research scientists in expanding our pipeline capabilities, as well as that of our CMC and Operations team with their industry-leading expertise in AAV gene therapy manufacturing,\u201d stated Ricardo Dolmetsch, Ph.D., president of research and development at uniQure. \u201cWe are particularly excited to share our progress in developing a &hellip; Continue reading &quot;uniQure Announces Major Presence at Upcoming\u00a0American Society of Gene and Cell Therapy (ASGCT) Annual Meeting&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/uniqure-announces-major-presence-at-upcoming-american-society-of-gene-and-cell-therapy-asgct-annual-meeting\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-05-02T22:44:27+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzMDQzMCM1NTcwNjk4IzIwODA0MDY=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/uniqure-announces-major-presence-at-upcoming-american-society-of-gene-and-cell-therapy-asgct-annual-meeting\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/uniqure-announces-major-presence-at-upcoming-american-society-of-gene-and-cell-therapy-asgct-annual-meeting\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"uniQure Announces Major Presence at Upcoming\u00a0American Society of Gene and Cell Therapy (ASGCT) Annual Meeting\",\"datePublished\":\"2023-05-02T22:44:27+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/uniqure-announces-major-presence-at-upcoming-american-society-of-gene-and-cell-therapy-asgct-annual-meeting\\\/\"},\"wordCount\":762,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/uniqure-announces-major-presence-at-upcoming-american-society-of-gene-and-cell-therapy-asgct-annual-meeting\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgzMDQzMCM1NTcwNjk4IzIwODA0MDY=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/uniqure-announces-major-presence-at-upcoming-american-society-of-gene-and-cell-therapy-asgct-annual-meeting\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/uniqure-announces-major-presence-at-upcoming-american-society-of-gene-and-cell-therapy-asgct-annual-meeting\\\/\",\"name\":\"uniQure Announces Major Presence at Upcoming\u00a0American Society of Gene and Cell Therapy (ASGCT) Annual Meeting - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/uniqure-announces-major-presence-at-upcoming-american-society-of-gene-and-cell-therapy-asgct-annual-meeting\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/uniqure-announces-major-presence-at-upcoming-american-society-of-gene-and-cell-therapy-asgct-annual-meeting\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgzMDQzMCM1NTcwNjk4IzIwODA0MDY=\",\"datePublished\":\"2023-05-02T22:44:27+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/uniqure-announces-major-presence-at-upcoming-american-society-of-gene-and-cell-therapy-asgct-annual-meeting\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/uniqure-announces-major-presence-at-upcoming-american-society-of-gene-and-cell-therapy-asgct-annual-meeting\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/uniqure-announces-major-presence-at-upcoming-american-society-of-gene-and-cell-therapy-asgct-annual-meeting\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgzMDQzMCM1NTcwNjk4IzIwODA0MDY=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgzMDQzMCM1NTcwNjk4IzIwODA0MDY=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/uniqure-announces-major-presence-at-upcoming-american-society-of-gene-and-cell-therapy-asgct-annual-meeting\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"uniQure Announces Major Presence at Upcoming\u00a0American Society of Gene and Cell Therapy (ASGCT) Annual Meeting\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"uniQure Announces Major Presence at Upcoming\u00a0American Society of Gene and Cell Therapy (ASGCT) Annual Meeting - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/uniqure-announces-major-presence-at-upcoming-american-society-of-gene-and-cell-therapy-asgct-annual-meeting\/","og_locale":"en_US","og_type":"article","og_title":"uniQure Announces Major Presence at Upcoming\u00a0American Society of Gene and Cell Therapy (ASGCT) Annual Meeting - Market Newsdesk","og_description":"LEXINGTON, Mass. and AMSTERDAM, May 02, 2023 (GLOBE NEWSWIRE) &#8212; uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced that 12 data presentations, including two oral presentations, will be delivered at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting being held May 16-20 in Los Angeles, California. \u201cOur presentations at ASGCT highlight the innovative work of our uniQure research scientists in expanding our pipeline capabilities, as well as that of our CMC and Operations team with their industry-leading expertise in AAV gene therapy manufacturing,\u201d stated Ricardo Dolmetsch, Ph.D., president of research and development at uniQure. \u201cWe are particularly excited to share our progress in developing a &hellip; Continue reading \"uniQure Announces Major Presence at Upcoming\u00a0American Society of Gene and Cell Therapy (ASGCT) Annual Meeting\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/uniqure-announces-major-presence-at-upcoming-american-society-of-gene-and-cell-therapy-asgct-annual-meeting\/","og_site_name":"Market Newsdesk","article_published_time":"2023-05-02T22:44:27+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzMDQzMCM1NTcwNjk4IzIwODA0MDY=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/uniqure-announces-major-presence-at-upcoming-american-society-of-gene-and-cell-therapy-asgct-annual-meeting\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/uniqure-announces-major-presence-at-upcoming-american-society-of-gene-and-cell-therapy-asgct-annual-meeting\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"uniQure Announces Major Presence at Upcoming\u00a0American Society of Gene and Cell Therapy (ASGCT) Annual Meeting","datePublished":"2023-05-02T22:44:27+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/uniqure-announces-major-presence-at-upcoming-american-society-of-gene-and-cell-therapy-asgct-annual-meeting\/"},"wordCount":762,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/uniqure-announces-major-presence-at-upcoming-american-society-of-gene-and-cell-therapy-asgct-annual-meeting\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzMDQzMCM1NTcwNjk4IzIwODA0MDY=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/uniqure-announces-major-presence-at-upcoming-american-society-of-gene-and-cell-therapy-asgct-annual-meeting\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/uniqure-announces-major-presence-at-upcoming-american-society-of-gene-and-cell-therapy-asgct-annual-meeting\/","name":"uniQure Announces Major Presence at Upcoming\u00a0American Society of Gene and Cell Therapy (ASGCT) Annual Meeting - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/uniqure-announces-major-presence-at-upcoming-american-society-of-gene-and-cell-therapy-asgct-annual-meeting\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/uniqure-announces-major-presence-at-upcoming-american-society-of-gene-and-cell-therapy-asgct-annual-meeting\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzMDQzMCM1NTcwNjk4IzIwODA0MDY=","datePublished":"2023-05-02T22:44:27+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/uniqure-announces-major-presence-at-upcoming-american-society-of-gene-and-cell-therapy-asgct-annual-meeting\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/uniqure-announces-major-presence-at-upcoming-american-society-of-gene-and-cell-therapy-asgct-annual-meeting\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/uniqure-announces-major-presence-at-upcoming-american-society-of-gene-and-cell-therapy-asgct-annual-meeting\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzMDQzMCM1NTcwNjk4IzIwODA0MDY=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzMDQzMCM1NTcwNjk4IzIwODA0MDY="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/uniqure-announces-major-presence-at-upcoming-american-society-of-gene-and-cell-therapy-asgct-annual-meeting\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"uniQure Announces Major Presence at Upcoming\u00a0American Society of Gene and Cell Therapy (ASGCT) Annual Meeting"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/753996","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=753996"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/753996\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=753996"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=753996"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=753996"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}